Eradicatus Infectus Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.98 M
- Satisfied Charges ₹ 9.59 M
- Revenue Growth -97.74%
- Profit Growth -246.35%
- Ebitda -155.14%
- Net Worth -8.28%
- Total Assets -11.67%
About Eradicatus Infectus
Eradicatus Infectus Private Limited (EIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 December 2019 (Five years and five months 9 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.98 M. The company has closed loans amounting to ₹9.59 M, as per Ministry of Corporate Affairs (MCA) records.
Manavi Anusha and Preeti Tank serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100DL2019PTC358370
- Company No.
358370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Eradicatus Infectus Private Limited
Explore comprehensive data for Eradicatus Infectus Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Eradicatus Infectus?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manavi Anusha  | Director | 04-Dec-2019 | Current |
| Preeti Tank | Director | 04-Dec-2019 | Current |
Financial Performance of Eradicatus Infectus.
Eradicatus Infectus Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 97.74% decrease. The company also saw a substantial fall in profitability, with a 246.35% decrease in profit. The company's net worth dipped by a decrease of 8.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eradicatus Infectus?
In 2023, Eradicatus Infectus had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Franco Alliance Private LimitedManavi Anusha and Preeti Tank are mutual person
- Pathstore Dx Rx India Private Limited
Manavi Anusha and Preeti Tank are mutual person
Charges (Loans)
Open Charges
₹0.98 M
Satisfied Charges
₹9.59 M
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2023 | Others | ₹0.98 M | Open |
| 26 Aug 2022 | Axis Bank Limited | ₹9.59 M | Satisfied |
How Many Employees Work at Eradicatus Infectus?
Eradicatus Infectus has a workforce of 8 employees as of Mar 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eradicatus Infectus, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eradicatus Infectus's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Eradicatus Infectus
Recent activity within the organization
- Annual General Meeting
Eradicatus Infectus Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Eradicatus Infectus Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge registered on 26 Aug 2022 via Charge ID 100606183 with Axis Bank Limited was fully satisfied on 15 Jan 2024.
- Charges
A charge with Others amounted to Rs. 0.98 M with Charge ID 100849026 was registered on 22 Dec 2023.
- Charges
A charge with Axis Bank Limited amounted to Rs. 9.59 M with Charge ID 100606183 was registered on 26 Aug 2022.
- Director Appointment
Manavi Anusha was appointed as a Director was appointed as a Director on 04 Dec 2019 & has been associated with this company since 5 years 5 months .
Frequently asked questions
What is the Incorporation or founding date of Eradicatus Infectus Private Limited?
Eradicatus Infectus Private Limited was incorporated on 04 Dec 2019.
What is authorized share capital and paid-up capital of Eradicatus Infectus Private Limited?
The authorized share capital of Eradicatus Infectus Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Eradicatus Infectus Private Limited?
Currently 2 directors are associated with Eradicatus Infectus Private Limited.
- Manavi Anusha
- Preeti Tank
What is the registered address of Eradicatus Infectus Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Eradicatus Infectus Private Limited is D-34 3Rd Floor Anand Niketan India, New Delhi, 110021.
What is the corporate identification number (CIN) and company number of Eradicatus Infectus Private Limited?
The corporate identification number (CIN) of Eradicatus Infectus Private Limited is U73100DL2019PTC358370 and the company number is 358370 as per Ministry of Corporate Affairs (MCA).
What is the official website of Eradicatus Infectus Private Limited?
The Official website of Eradicatus Infectus Private Limited is https://www.genestore.org
What has been the recent revenue trend for Eradicatus Infectus Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Eradicatus Infectus Private Limited has fallen by -97.74%.
How many employees does Eradicatus Infectus Private Limited currently have?
As Per 2024 financial reports, 8 employees are currently employed by Eradicatus Infectus Private Limited.
What change has been observed in the net worth of Eradicatus Infectus Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Eradicatus Infectus Private Limited has experienced an downturn of -8.28%.
What are the total open charges for Eradicatus Infectus Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Eradicatus Infectus Private Limited amount to ₹ 0.98 M.
When was the last Balance Sheet of Eradicatus Infectus Private Limited filed with the ROC?
The most recent Balance Sheet for Eradicatus Infectus Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records